Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jewish General Hospital
Montreal, Quebec, Canada
- Montreal General Hospital
Montreal, Quebec, Canada
- University of Montreal Hospital Group
Montreal, Quebec, Canada
- Azienda Ospedaliera Fatebenefratelli Milano
Milan, Italy
- Mbccop - San Juan
San Juan, Puerto Rico
- Galicia Hospital Universitario A Coruña
A Coruña, Galicia, Spain
- Madrid Quiron Madrid
Pozuelo de Alarcón, Madrid, Spain
- Cataluna Hospital Quiron de Barcelona
Barcelona, Spain
- Cataluna Hospital del Mar
Barcelona, Spain
- Extremadura Hospital San Pedro Alcantara
Cáceres, Spain
- Cataluna Hospital Amau de Vilanova de Lleida
Lleida, Spain
- Valencia Institut Valencia de Oncologia
Valencia, Spain
- Loma Linda University Medical Center
Loma Linda, California, United States
- Kaiser Permanente-San Diego
San Diego, California, United States
- Ccop - Colorado Cancer Research Program, Inc.
Denver, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Baptist Cancer Institute - Jacksonville
Jacksonville, Florida, United States
- St. Luke'S Mountain States Tumor Institute - Boise
Boise, Idaho, United States
- Kootenai Cancer Center
Post Falls, Idaho, United States
- Edward Cancer Center
Naperville, Illinois, United States
- Edward Cancer Center Plainfield
Plainfield, Illinois, United States
- Yorkville Family Practice
Yorkville, Illinois, United States
- St. Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- University of Kentucky Medical Center
Lexington, Kentucky, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- University of Missouri-Ellis Fischel
Columbia, Missouri, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- University Hospital and Medical Center - Suny Stony Brook
Stony Brook, New York, United States
- Ccop Carolinas Healthcare System
Charlotte, North Carolina, United States
- Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States
- Case Western Reserve University/university Hospitals of Cleveland
Cleveland, Ohio, United States
- Ccop - Dayton
Dayton, Ohio, United States
- Ccop - Dayton
Kettering, Ohio, United States
- Allegheny Cancer Center at Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Nsabp Foundation, Inc.
Pittsburgh, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- York Hospital
York, Pennsylvania, United States
- Roper Hosp & Med Asso (care Alliance Health)
Charleston, South Carolina, United States
- Spartanburg Regional Healthcare System
Spartanburg, South Carolina, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2010
- Primary completion
- 30 Sept 2015
- Completion
- 25 Nov 2016
- Last update posted
- 25 Oct 2021
- Registered enrollment
- 141
- Registry id
- NCT01008150
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.